XML 45 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 230,276 $ 483,610
Marketable securities 77,819 43,332
Accounts receivable - trade, net 593,207 28,254
Accounts receivable from Sanofi 99,913 74,781
Deferred tax assets 148,134   
Prepaid expenses and other current assets 56,663 35,800
Total current assets 1,206,012 665,777
Restricted cash and marketable securities 8,186 7,721
Marketable securities 271,230 275,887
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization 379,940 367,955
Deferred tax assets 192,022   
Other assets 23,100 6,243
Total assets 2,080,490 1,323,583
Current liabilities:    
Accounts payable and accrued expenses 111,345 95,625
Deferred revenue from Sanofi, current portion 17,022 20,011
Deferred revenue - other, current portion 33,809 31,629
Facility lease obligations, current portion 1,374 1,006
Total current liabilities 163,550 148,271
Deferred revenue from Sanofi 76,520 86,017
Deferred revenue - other 131,822 162,593
Facility lease obligations 159,436 159,508
Convertible senior notes 296,518 275,019
Other long term liabilities 7,259 6,443
Total liabilities 835,105 837,851
Commitments and contingencies (Note 13)      
Stockholders' equity:    
Preferred stock, $.01 par value; 30,000,000 shares authorized; issued and outstanding - none      
Additional paid-in capital 1,763,508 1,754,824
Accumulated deficit (517,054) (1,267,323)
Accumulated other comprehensive loss (1,166) (1,862)
Total stockholders' equity 1,245,385 485,732
Total liabilities and stockholders' equity 2,080,490 1,323,583
Class A Stock, convertible, $.001 par value; 40,000,000 shares authorized; shares issued and outstanding - 2,069,187 at December 31, 2012 and 2,109,512 at December 31, 2011
   
Stockholders' equity:    
Common stock 2 2
Common Stock, $.001 par value; 160,000,000 shares authorized; shares issued and outstanding - 95,223,525 at December 31, 2012 and 90,692,071 at December 31, 2011
   
Stockholders' equity:    
Common stock $ 95 $ 91